keyword
https://read.qxmd.com/read/38621732/effects-of-electroacupuncture-with-intestinal-disease-prescription-on-nlrp3-inflammasome-and-intestinal-mucosal-barrier-in-rats-with-acute-ulcerative-colitis
#1
JOURNAL ARTICLE
Ziwen Jiang, Ronglin Wu, Huichao Xu, Haijun Wang, Aiai Dong, Laixi Ji
OBJECTIVES: To observe the effects of electroacupuncture (EA) with "intestinal disease prescription" on the intestinal mucosal barrier and NLRP3 inflammasome in rats with dextran sulfate sodium (DSS)-induced acute ulcerative colitis (UC), and explore the underlying mechanism of EA with "intestinal disease prescription" for the treatment of UC. METHODS: Thirty-two healthy male SPF-grade SD rats were randomly divided into a blank group, a model group, a medication group, and an EA group, with 8 rats in each group...
April 12, 2024: Zhongguo Zhen Jiu, Chinese Acupuncture & Moxibustion
https://read.qxmd.com/read/38619721/real-world-treatment-patterns-and-healthcare-resource-use-for-ulcerative-colitis-and-crohn-s-disease-in-italy
#2
JOURNAL ARTICLE
Melania Dovizio, Susanne Hartz, Carlotta Buzzoni, Isabel Redondo, Marijana Nedeljkovic Protic, Domenico Birra, Valentina Perrone, Chiara Veronesi, Luca Degli Esposti, Alessandro Armuzzi
INTRODUCTION: Real-world data are used to inform decision-makers and optimise therapeutic management for patients with ulcerative colitis (UC) and Crohn's disease (CD). We analysed data on the epidemiology (by using proxies of prevalence and incidence), patient characteristics, treatment patterns and associated healthcare direct costs for the management of patients with UC and patients with CD in Italy. METHODS: This retrospective observational study used administrative databases from eight Local Health Units geographically distributed across Italy...
April 15, 2024: Advances in Therapy
https://read.qxmd.com/read/38599548/the-colon-targeting-efficacies-of-mesalazine-medications-and-their-impacts-on-the-gut-microbiome
#3
JOURNAL ARTICLE
Laura E McCoubrey, Nidhi Seegobin, Nannapat Sangfuang, Frédéric Moens, Hans Duyvejonck, Eline Declerck, Arno Dierick, Massimo Marzorati, Abdul W Basit
Successful treatment of ulcerative colitis (UC) is highly dependent on several parameters, including dosing regimen and the ability to deliver drugs to the disease site. In this study two strategies for delivering mesalazine (5-aminosalicylic acid, 5-ASA) to the colon were compared in an advanced in vitro model of the human gastrointestinal (GI) tract, the SHIME® system. Herein, a prodrug strategy employing bacteria-mediated drug release (sulfasalazine, Azulfidine®) was evaluated alongside a formulation strategy that utilised pH and bacteria-mediated release (5-ASA, Octasa® 1600 mg)...
April 8, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38595965/a-case-of-ulcerative-colitis-complicated-by-a-simple-appendiceal-opening
#4
Xiao Liu, Fang Fang, Qingfeng Luo
This case report describes the clinical course of a 64-year-old male with intermittent abdominal pain attributed to recurrent ulcers at the appendiceal orifice. Initial investigations in November 2019 revealed chronic gastritis and ulcers at the appendiceal orifice, prompting consideration of ulcerative colitis (UC). The patient responded well to mesalazine therapy, experiencing relief from symptoms and improved colonoscopy findings in May 2020. Despite discontinuing medication, a recurrence of symptoms in August 2021 led to a repeat colonoscopy showing renewed ulcers...
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38584003/corrigendum-to-the-effect-of-esomeprazole-on-the-upper-gi-tract-release-and-systemic-absorption-of-mesalazine-from-colon-targeted-formulations-int-j-pharm-619-2022-121701
#5
Arno Van Camp, Tim Vanuytsel, Joachim Brouwers, Patrick Augustijns
No abstract text is available yet for this article.
April 6, 2024: International Journal of Pharmaceutics
https://read.qxmd.com/read/38581647/inflammatory-bowel-disease-in-adults-experience-and-challenges-in-gastroenterology-practices-in-calabar-south-south-nigeria
#6
JOURNAL ARTICLE
M Kooffreh-Ada, E Chukwudike, T Ugbem, A E Itam-Eyo, O Uba-Mgbemena, I E Nwa, B A Eko, E I Effiong, A J Omotoso, G Kajogbola, U C Okonkwo, O E Ngim, R Ndoma-Egba
BACKGROUND: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract that is reported to be rare in Africans. The objective of this study is to share the experience of our Gastroenterology practice in Calabar, Cross River State on IBD. METHODS: This is a ten-year review of the records of patients visiting the Gastroenterology clinic of the University of Calabar Teaching Hospital and two private gastroenterology clinics in Calabar Municipality...
February 29, 2024: West African Journal of Medicine
https://read.qxmd.com/read/38579928/solubility-and-thermodynamics-of-mesalazine-in-aqueous-mixtures-of-poly-ethylene-glycol-200-600-at-293-2-313-2-k
#7
JOURNAL ARTICLE
Anali Ali Akbari, Aynaz Zarghampour, Nastaran Hashemzadeh, Salar Hemmati, Elaheh Rahimpour, Abolghasem Jouyban
In this study, the solubility of mesalazine was investigated in binary solvent mixtures of poly ethylene glycols 200/600 and water at temperatures ranging from 293.2 K to 313.2 K. The solubility of mesalazine was determined using a shake-flask method, and its concentrations were measured using a UV-Vis spectrophotometer. The obtained solubility data were analyzed using mathematical models including the van't Hoff, Jouyban-Acree, Jouyban-Acree-van't Hoff, mixture response surface, and modified Wilson models...
April 3, 2024: Annales Pharmaceutiques Françaises
https://read.qxmd.com/read/38576732/upadacitinib-for-refractory-ulcerative-colitis-with-primary-nonresponse-to-infliximab-and-vedolizumab-a-case-report
#8
Xuan Xu, Jing-Wen Jiang, Bing-Yun Lu, Xia-Xi Li
BACKGROUND: Many patients with ulcerative colitis (UC) do not respond well to, or tolerate conventional and biological therapies. There is currently no consensus on the treatment of refractory UC. Studies have demonstrated that the selective Janus kinase 1 inhibitor upadacitinib, a small-molecule drug, is effective and safe for treating UC. However, no studies have revealed that upadacitinib is effective in treating refractory UC with primary nonresponse to infliximab and vedolizumab...
March 26, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38565408/sarcandra-glabra-thunb-nakai-alleviates-dss-induced-ulcerative-colitis-by-promoting-restitution-restoring-barrier-function-and-modulating-il-17-notch1-foxp3-pathway-in-intestinal-cells
#9
JOURNAL ARTICLE
Shuling Zhang, Yanwu Li, Gang Chen, Xu Wang, Bin Wu
ETHNOPHARMACOLOGICAL RELEVANCE: Sarcandra glabra is officially named Zhong Jie Feng as a traditional medicine. In the nationality of Yao and Zhuang, it has been used to treat digestive diseases like stomachache and dysentery. Similarly, in Dai nationality, it has been used to treat intestinal diseases like gastric ulcers. However, the effect and mechanism of S. glabra on experimental ulcerative colitis (UC) are known. AIM OF STUDY: The main objective of this study was to investigate the effect and mechanism of S...
March 31, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38552442/the-significant-improvement-in-ovarian-pcos-syndrome-using-hydralazine-and-alendronate-aromatase-inhibitor-fda-approved-drugs-in-wistar-rat-models
#10
JOURNAL ARTICLE
Soudabeh Kavousipour, Fahimeh Koohnavard, Behzad Shahbazi, Ebrahim Eftekhar, Khadijeh Ahmadi
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. The aim of this study was to investigate the therapeutic potential of vitamin C, glutamine, mesalazine, hydralazine, and alendronate as new drug candidates for the treatment of letrozole-induced PCOS in female Wistar rats. PCOS was induced in rats by intramuscular injection of estradiol valerate (2 mg/kg body weight for 28 days). The rats then received normal saline (PCOS group), letrozole (0.5 mg/kg), vitamin C (100 mg/kg), glutamine (1000 mg/kg), mesalazine (200 mg/kg), hydralazine (30 mg/kg), and alendronate (17...
March 28, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38532806/ph-responsive-interface-conversion-efficient-oral-drug-delivery-platform-for-alleviating-inflammatory-bowel-disease
#11
JOURNAL ARTICLE
Yingying Zhao, Changqing Xu, Qing Liu, Xiaofei Lei, Li Deng, Fengyan Wang, Jing Yang
A key challenge for the effective treatment of intestinal diseases, including inflammatory bowel disease (IBD), is to develop an oral drug delivery system that can resist gastric acid erosion and efficiently release drugs after rapid entry into the intestine. In the present work, we developed oral composite nanoparticles (MSZ@PRHS) consisting of a rough mesoporous silica (RHS) loaded with Mesalazine (MSZ) and a CAP polymer membrane for targeted relief of inflammation in colitis. At the pH values of the simulated stomach and small intestine, the release rate of MSZ from MSZ@PRHS was low, while at the pH values of the simulated colon, the release rate of MSZ was high...
2024: Frontiers in Chemistry
https://read.qxmd.com/read/38525396/therapeutic-effects-of-tretinoin-and-caffeine-treated-bone-marrow-derived-mesenchymal-stem-cell-on-immunological-features-of-ulcerative-colitis-an-animal-model-study
#12
JOURNAL ARTICLE
Behnaz Movaffaghbani, Hadi Esmaeili Gouvarchinghaleh, Mahdieh Farzanehpour, Jalal Shayegh
BACKGROUND: Ulcerative colitis (UC) is one of the inflammatory gastrointestinal diseases. It causes irritation, inflammation, and ulcers in the digestive tract. UC is distinguished clinically by abdominal and rectal pain and intestinal secretion abnormalities. Mesenchymal stem cell (MSC) therapy could be the underlying treatment for UC. This study aimed to compare the results of MSC therapy with tretinoin and caffeine in an animal model. MATERIALS AND METHODS: Sixty male BALB/c mice were randomly divided into six equal groups...
2024: Advanced Biomedical Research
https://read.qxmd.com/read/38491514/identification-of-therapeutic-targets-in-osteoarthritis-by-combining-heterogeneous-transcriptional-datasets-drug-induced-expression-profiles-and-known-drug-target-interactions
#13
JOURNAL ARTICLE
Maria Claudia Costa, Claudia Angelini, Monica Franzese, Concetta Iside, Marco Salvatore, Luigi Laezza, Francesco Napolitano, Michele Ceccarelli
BACKGROUND: Osteoarthritis (OA) is a multifactorial, hypertrophic, and degenerative condition involving the whole joint and affecting a high percentage of middle-aged people. It is due to a combination of factors, although the pivotal mechanisms underlying the disease are still obscure. Moreover, current treatments are still poorly effective, and patients experience a painful and degenerative disease course. METHODS: We used an integrative approach that led us to extract a consensus signature from a meta-analysis of three different OA cohorts...
March 15, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38479421/-non-distinctive-abdominal-pain-is-it-diverticular-disease-or-not
#14
JOURNAL ARTICLE
Thomas Frieling
Acute abdominal pain may relate to specific organ systems and needs an interdisciplinary approach with close collaboration between internal and surgical disciplines. Main objective is to shorten the diagnostic work-up between the beginning of the symptoms and their therapy. After clarifying of the five w-questions: when, how, how long, why, and where, abdominal ultrasound, ECG, laboratory diagnostics and early application of computed tomography should be performed.For the most part, chronic abdominal pain is caused by disorders of the gut-brain-axis such as the irritable bowel syndrome...
March 2024: Deutsche Medizinische Wochenschrift
https://read.qxmd.com/read/38474043/an-in-vitro-study-evaluating-the-safety-of-mesalazine-on-human-nasoepithelial-cells
#15
JOURNAL ARTICLE
William Murphy, Sha Liu, Shari Javadiyan, Erich Vyskocil, Sholeh Feizi, Claudio Callejas, Peter-John Wormald, Sarah Vreugde, Alkis J Psaltis
Chronic rhinosinusitis (CRS) is a disease characterised by the inflammation of the nasal and paranasal cavities. It is a widespread condition with considerable morbidity for patients. Current treatment for chronic rhinosinusitis consists of appropriate medical therapy followed by surgery in medically resistant patients. Although oral steroids are effective, they are associated with significant morbidity, and disease recurrence is common when discontinued. The development of additional steroid sparing therapies is therefore needed...
February 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38467949/pyodermatitis-pyostomatitis-vegetans-a-case-report-and-systematic-review-focusing-on-oral-involvement
#16
JOURNAL ARTICLE
Bruno Ramos Chrcanovic, Roberta Rayra Martins-Chaves, Flávia Sirotheau Correa Pontes, Felipe Paiva Fonseca, Hélder Antônio Rebelo Pontes, Ricardo Santiago Gomez
BACKGROUND: Pyodermatitis-pyostomatitis vegetans (PPV) is a rare mucocutaneous disease characterized by multiple pustules and it is considered a marker for inflammatory bowel disease (IBD). The oral manifestations of this condition are referred to as pyostomatitis vegetans (PSV). PURPOSE: To investigate which features could help in establishing the diagnosis of PSV, with or without cutaneous lesions, based on information retrieved from all cases of PSV described in the literature...
March 12, 2024: Oral and Maxillofacial Surgery
https://read.qxmd.com/read/38467948/huang-qin-decoction-increases-slc6a4-expression-and-blocks-the-nf%C3%AE%C2%BAb-mediated-nlrp3-caspase1-gsdmd-pathway-to-disrupt-colitis-associated-carcinogenesis
#17
JOURNAL ARTICLE
Yili Tao, Lai Wang, Xiaofeng Ye, Xin Qian, Danye Pan, Xiaoyu Dong, Qian Jiang, Po Hu
Huang Qin decoction (HQD) is a traditional Chinese medicine formula for treating colitis, but the effects and molecular mechanism of action of HQD in colitis-associated carcinogenesis (CAC) are still unclear. Therefore, we aimed to determine the beneficial effects of HQD on CAC in mice and to reveal the underlying mechanism involved. AOM/DSS was used to induce CAC in mice, and the effects of HQD on tumorigenesis in mice were examined (with mesalazine serving as a positive control). Mesalazine or HQD treatment alleviated body weight loss and decreased the disease activity index in mice induced by AOM/DSS...
March 12, 2024: Functional & Integrative Genomics
https://read.qxmd.com/read/38458476/gut-immunomodulation-with-vedolizumab-prior-to-allogeneic-hematopoietic-stem-cell-transplantation-in-pediatric-patients-with-inflammatory-bowel-disease
#18
JOURNAL ARTICLE
Yogi Chopra, Karol Acevedo, Aleixo Muise, Karen Frost, Tal Schechter, Joerg Krueger, Muhammad Ali, Kuang-Yueh Chiang, V Y Kim, Eyal Grunebaum, Donna Wall
BACKGROUND: Inborn errors of immunity (IEI) are often associated with inflammatory bowel disease (IBD). IEI can be corrected by allogeneic hematopoietic stem cell transplantation (HSCT) however peri-transplantation intestinal inflammation may lead to increased risk of gut graft-versus-host disease (GVHD). Vedolizumab inhibits the homing of lymphocytes to the intestine and may attenuate gut GVHD, yet its role in preventing GvHD in pediatric patients with IEI-associated IBD has not been studied...
March 6, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38428656/anchang-yuyang-decoction-inhibits-experimental-colitis-related-carcinogenesis-by-regulating-ppar-signaling-pathway-and-affecting-metabolic-homeostasis-of-host-and-microbiota
#19
JOURNAL ARTICLE
Xiunan Wei, Junwei Liang, Jiahui Liu, Yonggang Dai, Xiaohui Leng, Yan Cheng, Lili Chi
ETHNOPHARMACOLOGICAL RELEVANCE: Inflammatory bowel disease (IBD) presents a risk of carcinogenesis, which escalates with the duration of IBD. Persistent histological inflammation is considered to be the driving factor of colitis carcinogenesis. Effective control of inflammation is helpful to prevent and treat colitis-related colorectal cancer (CAC). Anchang Yuyang Decoction (AYD), a traditional Chinese medicine (TCM) formula, is originated from the ancient prescription of TCM for treating colitis and colorectal cancer...
February 28, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38363897/intestinal-nontuberculous-mycobacteria-infection-a-case-report
#20
JOURNAL ARTICLE
Yanbin Xu, Jinfeng Yang, Lili Cui, Chengchen Huang, Chun Wu
BACKGROUND: Intestinal nontuberculous mycobacteriosis due to nontuberculous mycobacteria infection has clinical manifestations similar to intestinal tuberculosis and inflammatory bowel disease, causing difficulties in clinical diagnosis. CASE PRESENTATION: A 42-year-old male patient was admitted to the Sino-Japanese Friendship Hospital of Jilin University in June 2021 for diarrhea and intermittent hematochezia since April 2021. He was diagnosed with inflammatory intestinal disease by colonoscopy and midtransverse colon biopsy...
February 16, 2024: Medicine (Baltimore)
keyword
keyword
35710
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.